Global Pancreatic Endocrine Tumor Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Pancreatic Endocrine Tumor Drug

• 1.1 Definition of Pancreatic Endocrine Tumor Drug
• 1.2 Pancreatic Endocrine Tumor Drug Segment by Type
  • 1.2.1 Global Pancreatic Endocrine Tumor Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Buparlisib Hydrochloride
  • 1.2.3 Dovitinib Lactate
  • 1.2.4 Fosbretabulin Tromethamine
  • 1.2.5 Lanreotide Acetate
  • 1.2.6 MPHE-001B
  • 1.2.7 Others
• 1.3 Pancreatic Endocrine Tumor Drug Segment by Applications
  • 1.3.1 Global Pancreatic Endocrine Tumor Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Research Center
  • 1.3.4 Hospital
• 1.4 Global Pancreatic Endocrine Tumor Drug Overall Market
  • 1.4.1 Global Pancreatic Endocrine Tumor Drug Revenue (2014-2025)
  • 1.4.2 Global Pancreatic Endocrine Tumor Drug Production (2014-2025)
  • 1.4.3 North America Pancreatic Endocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Pancreatic Endocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.5 China Pancreatic Endocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Pancreatic Endocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Pancreatic Endocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.8 India Pancreatic Endocrine Tumor Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Pancreatic Endocrine Tumor Drug
• 2.3 Manufacturing Process Analysis of Pancreatic Endocrine Tumor Drug
• 2.4 Industry Chain Structure of Pancreatic Endocrine Tumor Drug

3 Development and Manufacturing Plants Analysis of Pancreatic Endocrine Tumor Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Pancreatic Endocrine Tumor Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Pancreatic Endocrine Tumor Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Pancreatic Endocrine Tumor Drug Production and Capacity Analysis
• 4.2 Pancreatic Endocrine Tumor Drug Revenue Analysis
• 4.3 Pancreatic Endocrine Tumor Drug Price Analysis
• 4.4 Market Concentration Degree

5 Pancreatic Endocrine Tumor Drug Regional Market Analysis

• 5.1 Pancreatic Endocrine Tumor Drug Production by Regions
  • 5.1.1 Global Pancreatic Endocrine Tumor Drug Production by Regions
  • 5.1.2 Global Pancreatic Endocrine Tumor Drug Revenue by Regions
• 5.2 Pancreatic Endocrine Tumor Drug Consumption by Regions
• 5.3 North America Pancreatic Endocrine Tumor Drug Market Analysis
  • 5.3.1 North America Pancreatic Endocrine Tumor Drug Production
  • 5.3.2 North America Pancreatic Endocrine Tumor Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Pancreatic Endocrine Tumor Drug Import and Export
• 5.4 Europe Pancreatic Endocrine Tumor Drug Market Analysis
  • 5.4.1 Europe Pancreatic Endocrine Tumor Drug Production
  • 5.4.2 Europe Pancreatic Endocrine Tumor Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Pancreatic Endocrine Tumor Drug Import and Export
• 5.5 China Pancreatic Endocrine Tumor Drug Market Analysis
  • 5.5.1 China Pancreatic Endocrine Tumor Drug Production
  • 5.5.2 China Pancreatic Endocrine Tumor Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Pancreatic Endocrine Tumor Drug Import and Export
• 5.6 Japan Pancreatic Endocrine Tumor Drug Market Analysis
  • 5.6.1 Japan Pancreatic Endocrine Tumor Drug Production
  • 5.6.2 Japan Pancreatic Endocrine Tumor Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Pancreatic Endocrine Tumor Drug Import and Export
• 5.7 Southeast Asia Pancreatic Endocrine Tumor Drug Market Analysis
  • 5.7.1 Southeast Asia Pancreatic Endocrine Tumor Drug Production
  • 5.7.2 Southeast Asia Pancreatic Endocrine Tumor Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Pancreatic Endocrine Tumor Drug Import and Export
• 5.8 India Pancreatic Endocrine Tumor Drug Market Analysis
  • 5.8.1 India Pancreatic Endocrine Tumor Drug Production
  • 5.8.2 India Pancreatic Endocrine Tumor Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Pancreatic Endocrine Tumor Drug Import and Export

6 Pancreatic Endocrine Tumor Drug Segment Market Analysis (by Type)

• 6.1 Global Pancreatic Endocrine Tumor Drug Production by Type
• 6.2 Global Pancreatic Endocrine Tumor Drug Revenue by Type
• 6.3 Pancreatic Endocrine Tumor Drug Price by Type

7 Pancreatic Endocrine Tumor Drug Segment Market Analysis (by Application)

• 7.1 Global Pancreatic Endocrine Tumor Drug Consumption by Application
• 7.2 Global Pancreatic Endocrine Tumor Drug Consumption Market Share by Application (2014-2019)

8 Pancreatic Endocrine Tumor Drug Major Manufacturers Analysis

• 8.1 Ipsen S.A.
  • 8.1.1 Ipsen S.A. Pancreatic Endocrine Tumor Drug Production Sites and Area Served
  • 8.1.2 Ipsen S.A. Product Introduction, Application and Specification
  • 8.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Jiangsu Hengrui Medicine Co., Ltd.
  • 8.2.1 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Production Sites and Area Served
  • 8.2.2 Jiangsu Hengrui Medicine Co., Ltd. Product Introduction, Application and Specification
  • 8.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 MediaPharma s.r.l.
  • 8.3.1 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Production Sites and Area Served
  • 8.3.2 MediaPharma s.r.l. Product Introduction, Application and Specification
  • 8.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Novartis AG
  • 8.4.1 Novartis AG Pancreatic Endocrine Tumor Drug Production Sites and Area Served
  • 8.4.2 Novartis AG Product Introduction, Application and Specification
  • 8.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 OXiGENE, Inc.
  • 8.5.1 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Production Sites and Area Served
  • 8.5.2 OXiGENE, Inc. Product Introduction, Application and Specification
  • 8.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Pancreatic Endocrine Tumor Drug Market

• 9.1 Global Pancreatic Endocrine Tumor Drug Market Trend Analysis
  • 9.1.1 Global Pancreatic Endocrine Tumor Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Pancreatic Endocrine Tumor Drug Regional Market Trend
  • 9.2.1 North America Pancreatic Endocrine Tumor Drug Forecast 2019-2025
  • 9.2.2 Europe Pancreatic Endocrine Tumor Drug Forecast 2019-2025
  • 9.2.3 China Pancreatic Endocrine Tumor Drug Forecast 2019-2025
  • 9.2.4 Japan Pancreatic Endocrine Tumor Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Pancreatic Endocrine Tumor Drug Forecast 2019-2025
  • 9.2.6 India Pancreatic Endocrine Tumor Drug Forecast 2019-2025
• 9.3 Pancreatic Endocrine Tumor Drug Market Trend (Product Type)
• 9.4 Pancreatic Endocrine Tumor Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Pancreatic Endocrine Tumor Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List